Journal of Family Medicine and Primary Care

REVIEW ARTICLE
Year
: 2021  |  Volume : 10  |  Issue : 5  |  Page : 1808--1813

Remdesivir – Current evidence & perspective in management of COVID-19 infection


Jyoti Bajpai1, Surya Kant1, Akshyaya Pradhan2, Ajay K Verma1 
1 Department of Respiratory, King George's Medical University, Lucknow, Uttar Pradesh, India
2 Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India

Correspondence Address:
Dr. Surya Kant
Professor and Head Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh - 226 003
India

Coronavirus infection or COVID 19 was first reported in December 2019 in Wuhan, China, and has rapidly spread to more than 200 countries. The pandemic has also taken a toll of over 2.2 million. But the elusive search for an effective antidote is still on. Pending multiple and robust randomized controlled studies, some drugs are being used globally based on in-vitro studies, in -vivo evidence, observational studies, and small nonrandomized studies. Remdesivir is a nucleotide analog. It inhibits viral RNA-dependent RNA polymerase enzyme. Several studies have hitherto demonstrated the promising in-vitro and in-vivo antiviral activities of the molecule against severe acute respiratory syndrome coronavirus (SARS-CoV-1) and the Middle East respiratory syndrome coronavirus (MERS-CoV) strains. It has now exhibited potential in vitro activity against SARS-CoV-2 strains too. Based on pivotal studies, remdesivir is now being used to treat moderate to severe patients through emergency use authorizations and other access programs around the world. This review aims to summarize the evidence and clinical trials of remdesivir as a potential therapeutic option for COVID-19.


How to cite this article:
Bajpai J, Kant S, Pradhan A, Verma AK. Remdesivir – Current evidence & perspective in management of COVID-19 infection.J Family Med Prim Care 2021;10:1808-1813


How to cite this URL:
Bajpai J, Kant S, Pradhan A, Verma AK. Remdesivir – Current evidence & perspective in management of COVID-19 infection. J Family Med Prim Care [serial online] 2021 [cited 2021 Jun 13 ];10:1808-1813
Available from: https://www.jfmpc.com/article.asp?issn=2249-4863;year=2021;volume=10;issue=5;spage=1808;epage=1813;aulast=Bajpai;type=0